IL33 and cholangiocarcinoma: Yamada et al. [163] and Li et al. [164] showed that the biliary mitogen IL-33 facilitates oncogene-induced cholangiocarcinoma (CCA) in mice through constitutively activating AKT and YAP oncogenes.